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Amelioration of aluminium-induced liver damage by 
vitamin E
Recep Kutlubay, MSc, PhD, Emin O. Oguz, MD, PhD, Gulcin Abban, MSc, PhD, Sebahat Turgut, DVM, PhD.
Aluminium, the third most abundant element of the Earth’s crust, is a non-essential and toxic metal in 
humans.1-4 Aluminium and its salts are commonly used 
in daily life, a widespread use that was enhanced by the 
belief that it is non-toxic and is quickly excreted from the 
body in the urine. However, this element has a negative 
impact on human health.5 Due to its abundance, every 
organism contains small quantities of aluminium,4,6,7 
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ABSTRACT
Objective: To investigate the effects of aluminium 
sulphate on the microscopic morphology of the liver 
and on vitamin E amelioration of aluminium-induced 
liver damage. 
Methods: Rats were injected intraperitoneally with 
aluminium sulphate alone or aluminium sulphate 
together with vitamin E, with saline injected rats 
used as the control group. The study took place in 
Pamukkale University Faculty of Medicine in 2005. 
Results: The rats exposed to aluminium showed 
morphological changes in addition to previously 
reported biochemical changes in the liver. The anti-
oxidant vitamin E significantly diminished the liver 
damage seen due to aluminium. 
Conclusion: There is an apparent protective effect of 
vitamin E on parenteral aluminium exposure.
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and it can be found in practically all of the tissues of 
mammals, including the brain, liver, kidney, heart, 
blood, and bones.1-3,8 Aluminium accumulation in the 
liver leads to cholestasis.5 There has been considerable 
debate as to whether chronic exposure to aluminium 
is involved in neuro-degenerative disorders, such as 
Alzheimer’s disease,9-12 dialysis, Parkinson’s dementia,13,14 
and hepatotoxicity.15,16 The toxic effects of aluminium 
appear to be mediated, at least in part, by free-radical 
generation.17,18 The treatment commonly used in 
aluminium disorders is desferrioxamine.19 However, 
desferrioxamine therapy is associated with undesirable 
side effects, it is very expensive, and it is only efficient 
when applied intravenously or subcutaneously.20 
The goal of this study was to investigate the effects 
of aluminium exposure on liver tissue. The potential 
protective effects of the anti-oxidant vitamin E on these 
aluminium effects on the liver were also analyzed. 
Methods. Adult male albino Wistar rats weighing 
180-200 g were housed in the Experimental Research 
Unit of the University of Pamukkale, Denizli, Turkey 
in 2005. They were reared under the supervision of 
a veterinarian, kept in a well-ventilated, noiseless 
environment, and allowed free access to food and 
water. The male animals were selected at random and 
divided into 4 groups; each group included 7 rats. The 
first, control group of rats was injected with saline (2 
ml/200 g body weight), and the second group was 
injected with aluminium sulphate (one mg/200 g body 
weight) dissolved in saline. The third group of rats were 
injected with both aluminium sulphate (one mg/200 
g body weight) dissolved in saline and vitamin E (100 
mg/200 g body weight), while the fourth group of rats 
were injected with vitamin E only (100 mg/200 g body 
weight). The injections were performed intraperitoneally 
for a period of 2 weeks (3 times per week, namely, on 
Mondays, Wednesdays and Fridays), and at the end of 
the second week, they were sacrificed under anesthesia. 
The liver tissues of each rat were collected and processed 
for routine histology; they were sectioned, stained with 
hematoxylin and eosin, and analyzed and photographed 
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under light microscopy. The study was approved by 
the Pamukkale University Ethical Committee for 
Experimental Animals.
Results. In contrast to the liver samples from 
the control group (Figure 1), dilatation and bleeding 
areas were seen in the liver sinusoids in the rats in the 
aluminium group (group 2). There were spaces between 
the hepatocytes and some impairment in the radial 
arrangement around them. Significant cytoplasmic 
loss was seen with most of the group 2 hepatocytes; 
some of these also showed cell membrane defects and 
spacing around their nuclei. Some also showed nuclei 
that were greatly enlarged and with some indentations, 
while in others, the nuclei were small and ellipsoid in 
shape (Figure 2). In the group 3 rats, which had been 
co-exposed to aluminium and vitamin E, the liver 
tissues appeared almost normal. There was no sinusoidal 
dilatation or bleeding foci. Although there were some 
relatively small cytoplasmic spacing around the nuclei 
in some of these group 3 hepatocytes, they appeared to 
be much less damaged than those of the group 2 rats 
(Figure 3). The liver tissues in the rats given only vitamin 
E (group 4) had the same appearance as those of the 
control group (compare Figure 4 and Figure 1).
Discussion. Previous studies on aluminium toxicity 
have been based on biochemical analysis.19,21-26 Thus, 
it has been seen that aluminium accumulation within 
the liver is associated with a number of biochemical 
changes, which include the release of enzyme markers 
of liver injury, and alterations in the oxidant status.17,26 
Our light microscopy findings following aluminium 
exposure of rat liver tissue show structural changes 
in the sinusoids that are accompanied by hepatocyte 
column and cytoplasmic, nuclear, and cell membrane 
alterations in these hepatocytes, all of which support 
the previously reported biochemical alterations that 
have been reported to be due to aluminium damage 
to the liver. Our findings therefore add to our current 
Figure 1 - Liver samples from group I rats (controls). Vena 
centralis (VC), sinusoid (thin arrow), hepatocyte 
(thick arrow). Stained with hematoxylin and 
eosin. Original magnification: 10x.
Figure 2 - Liver samples from group II rats (aluminium 
treated). Sinusoid (thin arrow), hepatocyte (thick 
arrow). Stained with hematoxylin and eosin. 
Original magnification: 40x.
Figure 3 - Liver samples from group III rats (aluminium + 
vitamin E). Vena centralis (VC), sinusoid (thin 
arrow), hepatocyte (thick arrow). Stained with 
hematoxylin and eosin. Original magnification: 
10x.
Figure 4 - Liver samples from group IV rats (vitamin E 
alone). Vena centralis (VC), sinusoid (thin 
arrow), hepatocyte (thick arrow). Stained with 
hematoxylin and eosin. Original magnification: 
20x.
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knowledge of liver pathology in terms of aluminium 
damage, and they are relevant to those cases where liver 
biopsies have been obtained from people who have been 
exposed to environmental or work-place aluminium for 
certain lengths of time. 
The treatment commonly used in aluminium 
disorders is desferrioxamine, which is a chelator that has 
a large capacity to decrease the aluminium body burden 
by increasing its excretion in the urine.19 However, as 
indicated above, it is only efficient when it is applied 
intravenously or subcutaneously and it has been shown 
that desferrioxamine therapy has side effects that are 
often not well tolerated.20 Thus, its application limits 
the success of this therapy, while it has also been seen 
to be an expensive treatment.20 Aluminium treatment 
has been associated with significantly reduced vitamin 
E concentrations in the plasma, which might be due 
to increased processing of this antioxidant due to the 
increased levels of oxidant stress.22 Previous studies 
have also shown that as an antioxidant, vitamin E may 
improve the pro-oxidant effects of aluminium. Kenneth 
et al,27 reported that antioxidants can protect mouse 
hepatocytes from aluminium toxicity, while Chinoy and 
Memon,28 reported partial protection from aluminium-
induced hepatotoxicity in the rat with vitamins E 
and C. Perhaps more surprisingly, dietary vitamin E 
supplementation has been associated with a significant 
reduction in the plasma and hepatic concentrations of 
aluminium.22
In the present study, vitamin E was demonstrated to 
serve as an antioxidant, and to prevent the degenerative 
effects of aluminium on the microscopic morphology 
of rat liver tissue. The dilatations in the sinusoids were 
significantly reduced, and the hepatocyte columns 
maintained a normal structure in the aluminium plus 
vitamin E co-exposed group. In addition to this, the 
cytoplasmic spacing around the nuclei was no longer 
seen, and the hepatocyte nuclei had a normal appearance. 
The results of this study thus clearly demonstrate that 
vitamin E co-treatment under aluminium exposure 
ameliorates the histological alterations in the liver tissue 
that is caused by aluminium exposure by itself. On 
the other hand, the livers of the rats treated only with 
vitamin E were histologically comparable to those in the 
control group, suggesting that vitamin E itself has no 
observable side effects. In addition, vitamin E is much 
more cost efficient in comparison to desferrioxamine. 
Thus, this study indicates that vitamin E can be used 
clinically as a protective treatment against the adverse 
effects of aluminium. It will also be important to 
evaluate the effects of such aluminium exposure in liver 
tissue, and its amelioration by vitamin E, at the electron 
microscopy level in order to strengthen these findings.
In conclusion, our findings in the present study 
are in agreement with those of Abubakar et al.22 Thus, 
aluminium administration appears to increase the 
oxidant stress in the liver, and this is an effect that can 
be offset by concomitant dietary vitamin E, which could 
be acting via aluminium absorption or excretion. 
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